Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
Date:9/8/2009

>

                               PALATIN TECHNOLOGIES, INC.
                       Consolidated Statement of Operations Data
                                      (unaudited)


                                Year Ended June 30,     Quarter Ended June 30,
                                  2009          2008        2009         2008

    REVENUES               $11,351,774   $11,483,287  $4,227,070   $1,015,764

    OPERATING EXPENSES:
      Research and
       development          13,356,751    21,187,762   3,045,423    4,891,494
      General and
       administrative        5,296,859     6,928,295   1,415,171    1,460,066
        Total operating
         expenses           18,653,610    28,116,057   4,460,594    6,351,560

        Loss from
         operations         (7,301,836)  (16,632,770)   (233,524)  (5,335,796)

    OTHER INCOME (EXPENSE):
      Investment income        233,319     1,030,452      38,137      122,162
      Interest expense         (26,159)      (73,495)     (5,143)     (28,661)
      Gain on sale of
       property and equipment  550,968             -           -            -
        Total other income,
         net                   758,128       956,957      32,994       93,501

        Loss before income
         taxes              (6,543,708)  (15,675,813)   (200,530)  (5,242,295)
    Income tax benefit       1,741,476     1,291,444           -            -

    NET LOSS               $(4,802,232) $(14,384,369)  $(200,530) $(5,242,295)

    Basic and diluted net
     loss per common share      $(0.06)       $(0.17)     $(0.00)      $(0.06)

    Weighted average number
     of common shares
     outstanding used in
     computing basic and
     diluted net loss per
     common share           86,370,306    85,220,575  86,662,901   85,297,321

                              PALATIN TECHNOLOGIES, INC.
                            Consolidated Balan
'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... 19, 2014 NextCODE Health, which enables clinicians and ... real time, today announced the launch of its new genomic ... at the American Society of Human Genetics (ASHG) annual meeting ... sign up and apply for free beta access, visit ... benefits can be viewed here . The ...
(Date:10/19/2014)... report "Chocolate, Cocoa Beans, Lecithin, Sugar and Vanilla Market ... (2011 - 2016)," analyzes the chocolate market by ... market drivers, restraints, and opportunities for the chocolate market ... chocolate market is expected to grow from $83.2 billion ... CAGR of 2.7% from 2011 to 2016. , Get ...
(Date:10/18/2014)... The “Human Insulin Market- by Product ... Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], ... Others) - Forecast to 2018” provides a detailed ... current market trends, and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:10/18/2014)... Asia-Pacific hardware encryption display market report defines and segments ... of revenue. This market was valued $5,154.0 million in ... 2018, at a CAGR of 58.4% from 2013 to ... hardware encryption market report, to get an idea of ... of the segmentation of the market, and is supported ...
Breaking Biology Technology:The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3
... WEST CONSHOHOCKEN, Pa., Nov. 12 GEL Interactive,Technologies, ... Kent,Senior Product Director, will be a featured speaker ... Annual Forum on Defining Appropriate,and Effective Interactions with ... 5th Annual Forum provides a platform for attendees ...
... MELBOURNE, Australia, Nov. 12 Phosphagenics,Limited ("Phosphagenics") (ASX: ... initiated a phase 1 human clinical trial ... the targeted delivery of a leading non ... compare the,bioavailability and penetration of the topically ...
... EMERYVILLE, Calif., Nov. 12 Bionovo, Inc.,(Nasdaq: BNVI ... to the,company,s Scientific Advisory Board. Dr. Weiss is a ... a leading researcher,at the Cardiovascular Research Institute and the ... (UCSF)., "We are very excited to have Ethan ...
Cached Biology Technology:Cadient Group's GEL Interactive Technologies to Present and Exhibit at CBI's 5th Annual Forum 2Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans 2Ethan Weiss, M.D., Joins Bionovo's Scientific Advisory Board 2Ethan Weiss, M.D., Joins Bionovo's Scientific Advisory Board 3
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
(Date:10/15/2014)... is spreading rapidly and to an unexpected extent. The ... past and the virus shows a new disease dynamic ... For this reason, the German National Academy of Sciences ... Engineering, and the Union of the German Academies of ... Ebola epidemic today. , In the statement the academies ...
Breaking Biology News(10 mins):New report synthesizes best available science on management of moist mixed-conifer forests 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
... a share of grants totalling over 1m to target ... Dr. Declan Bates, a senior lecturer in the Department ... of 1,068,000 in the form of just two research ... Council (EPSRC) and the other from the Biotechnology and ...
... molecular mechanisms by which plants protect themselves from oxidation ... a team of researchers has discovered a molecular dimmer ... moving through the system of light harvesting proteins. This ... artificial photosynthesis systems that could provide the world with ...
... Fla. Two University of Miami (UM) students have ... Foundation (NSF) for their doctoral work on coral reefs. ... years of support for their work in the laboratory ... Division of Marine Biology and Fisheries at UMs Rosenstiel ...
Cached Biology News:Engineer to spearhead research into cell metabolism and medical injuries 2Berkeley researchers identify photosynthetic dimmer switch 2Berkeley researchers identify photosynthetic dimmer switch 3Berkeley researchers identify photosynthetic dimmer switch 4Everything's coming up corals 2Everything's coming up corals 3
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... incubation trays are disposable trays ... antigens that have been blotted ... has eight 10.5 cm x ... strips cut from blotted membrane ...
... in permanent mounting media. It is ... immunohistochemical organic insoluble substrates such as ... and any other organic solvent compatible ... can be used for histology and ...
... The Gene Inspector can perform many sophisticated DNA ... is much more than just another sequence analysis ... entire suite of analyses to be performed each ... design custom style sheets which specify exactly how ...
Biology Products: